Do you have adolescent patients
living with atopic dermatitis?

Doing great work takes commitment and focus.Just like SCCHN research.

We are advancing research in atopic dermatitis in adolescents.

Consider one of the following studies for your adolescent patients with atopic dermatitis.
The SUN and MOON studies measure the effectiveness of various dosage amounts of adermtuximab cream on AD.
The STARS study is measuring the effectiveness of ligitimus therapy on AD.

SUN and MOON Studies

Download the SUN and MOON brochures for the parents or guardians of your adolescent patients with atopic dermatitis.

Copy the SUN patient website link into your patient notes.

Copy the MOON patient website link into your patient notes.

block background

STARS STUDY

Download the STARS study brochure for the parents or guardians of your adolescent patients with atopic dermatitis.

Brochure download

Copy the patient website link into your patient notes.

block background
Image

Inclusion & Exclusion Criteria

Who can participate in the SUN study for adolescent atopic dermatitis?

Patients who meet the following criteria may qualify:

12-17 years of age

Documented diagnosis of atopic dermatitis

2 or more AD flares within the last 12 months

This is not a complete list of eligibility criteria. Click below to see full criteria.

Study Summary

Image

Study Drug:

Adermtuximab
twice a week

Image

Participant Age:

12-17

Image

Sponsor:

DermaticEffect Pharma

Image

Enrollment Period:

Currently enrolling

Image

Inclusion & Exclusion Criteria

Who can participate in the MOON study for adolescent atopic dermatitis?

Patients who meet the following criteria may qualify:

12-17 years of age

Documented diagnosis of atopic dermatitis

2 or more AD flares within the last 12 months

This is not a complete list of eligibility criteria. Click below to see full criteria.

Study Summary

Image

Study Drug:

Adermtuximab
cream once daily

Image

Participant Age:

12-17

Image

Sponsor:

DermaticEffect Pharma

Image

Enrollment Period:

Currently enrolling

Image

Inclusion & Exclusion Criteria

Who can participate in the STARS study for adolescent patients with atopic dermatitis?

Patients who meet the following criteria may qualify:

12-17 years of age

Documented diagnosis of atopic dermatitis

2 or more AD flares within the last 12 months

This is not a complete list of eligibility criteria. Click below to see full criteria.

Study Summary

Image

Study Drug:

Ligitimus therapy

Image

Participant Age:

12-17

Image

Sponsor:

DermaticEffect Pharma

Image

Enrollment Period:

Currently enrolling

map background

Study Site Locations

Click on the map below for study site locations near you and their contact information.

Location

Click to copy study site locations near you into your patient notes.